Tavicare Provides FDA-Approved COVID-19 Monoclonal Antibody IV Therapy to High-Risk Patients in Maryland

The initiative taken by the Maryland-based clinic reflects a strong commitment to saving lives and promoting healthy living.

Chevy Chase, MD, 13th July 2022, ZEXPRWIRE, The year 2021 saw various preventive measures for COVID-19, including vaccination, practicing social distancing such as staying six feet apart, wearing a mask in crowded areas and washing hands frequently. Tavicare, a leading healthcare provider in Chevy Chase now provides FDA-approved COVID-19 Monoclonal Antibody IV therapy to high-risk patients infected with COVID-19 in Maryland.

COVID-19 is caused by SARS-CoV-2, which causes mild to severe respiratory illness. The most common symptoms include fever, cough, sore throat, severe headache, shortness of breath and loss of taste or smell. It affects everyone differently; some develop moderate symptoms and recover without hospitalization.

However, some people are at greater risk for developing severe conditions, especially those who are not vaccinated or have weaker immune systems.

The Monoclonal Antibody IV therapy helps avoid the need for hospitalization. It is administered using IVs or a single-dose injection to patients diagnosed with the virus. In this therapy, COVID-19 antibodies help a person’s body fight off the infection.

Research indicates that the injection has a lower dosage than the infusion therapy.

Tavicare offers healthcare services that are effective and reliable solutions for various medical needs. From hormonal therapy to depression treatment, experts at Tavicare provide therapies to help improve their patients’ overall health and well-being.

When asked about this initiative, Tavicare founder, President, and CEO, Dr. Delara K. Tavakoli, shared: “With the initiative of monoclonal antibody treatment, we aim to help keep high-risk patients with COVID-19 out of the hospital. This is the need of the hour as we can see new variants emerging every other day. Anti-SARS-CoV-2 mAbs treatment should be started right after SARS-CoV-2 infection is confirmed by an antigen test or if a patient has symptoms for seven days.”

At Tavicare, It is administered properly and in a particular setting so that allergic reactions can be managed as soon as possible. Patients are monitored thoroughly throughout the infusion and even afterward for at least an hour.

About Tavicare

Tavicare is a functional care practice dedicated to helping individuals live their best life. Dr. Tavakoli and her highly-experienced medical staff offer personalized care and treatment for diseases like menopause, low libido, low testosterone, hyperthyroidism, depression, and cancer.

Media Contacts

Company Name: Tavicare Inc

Email: [email protected]

Website: https://tavicare.com/

Phone number: (301) 917-3200

Business Hours: Mon – Fri 9:00am-5:00pm

Address: 5530 Wisconsin Ave., Ste. 1125, Chevy Chase, MD

Contact Form: https://tavicare.com/contact-tavicare/

The post Tavicare Provides FDA-Approved COVID-19 Monoclonal Antibody IV Therapy to High-Risk Patients in Maryland appeared first on Zex PR Wire.

Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

Previous articleFitEngine Will Give You The Latest And Hottest Fitness Resources in NY
Next articleHustle Mama Magazine Encourages Women To Get Out Of Their Comfort Zone And Try New Things Such As Starting A Business, Traveling Alone, And Learning New Skills Through Their Digital Magazine